Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours:: a Single Technology Appraisal

Cooper, Keith, Kalita, Neelam, Souto Ribeiro, Inês, Woods, Lois, Scott, David Alexander and Frampton, Geoff (2020) Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours:: a Single Technology Appraisal (Health Technology Assessment, HTA - NIHR131435) Southampton, UK. National Institute for Health and Care Research 119pp.

Record type: Monograph (Project Report)

Abstract

This report is a critique of the company’s submission (CS) to NICE from Blueprint Medicines on the clinical effectiveness and cost effectiveness of avapritinib for treating gastrointestinal stromal tumours. It identifies the strengths and weaknesses of the CS.

Text

Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours - Evidence Review Group report - Version of Record

Available under License Other.

Download (2MB)

More information

Published date: 2020

Related URLs:

Identifiers

Local EPrints ID: 446845

URI: http://eprints.soton.ac.uk/id/eprint/446845

PURE UUID: 4ee640fa-50a5-4cb0-a1d9-c8f73efa03f7

ORCID for Keith Cooper:

orcid.org/0000-0002-0318-7670

ORCID for Neelam Kalita:

orcid.org/0000-0002-0973-0160

ORCID for Lois Woods:

orcid.org/0000-0002-4587-9149

ORCID for David Alexander Scott:

orcid.org/0000-0001-6475-8046

ORCID for Geoff Frampton:

orcid.org/0000-0003-2005-0497

Catalogue record

Date deposited: 24 Feb 2021 17:31

Last modified: 10 Apr 2024 02:03

Export record

Share this record

Share this on Facebook Share this on Twitter Share this on Weibo

Contributors

Author: Keith Cooper

Author: Neelam Kalita

Author: Inês Souto Ribeiro

Author: Lois Woods

Author: David Alexander Scott

Author: Geoff Frampton

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information